Characteristics of participants
| Children with cystic fibrosis | ||||
| Pseudonyms | Gender | Age group (years) | Time on elexacaftor-tezacaftor-ivacaftor (months) | Latest lung function result (FEV1 %) |
| Rose | Female | 16–18 | 16 | 91 |
| Elisa | Female | 16–18 | 15 | 104 |
| Anna | Female | 12–15 | 6 | 92 |
| Maggie | Female | 16–18 | 15 | 103 |
| Arthur | Male | 12–15 | 17 | 103 |
| Pippa | Female | 16–18 | 18 | 102 |
| David | Male | 12–15 | 18 | 98 |
| Sonny | Male | 12–15 | 18 | 110 |
| Ruby | Female | 12–15 | 11 | 88 |
| Elizabeth | Female | 12–15 | 16 | 106 |
| Parents/carers | ||||
| Pseudonyms | Gender | Age group of child (years) | ||
| Amy | Female | 16–18 | ||
| Martha | Female | 12–15 | ||
| Olivia | Female | 12–15 | ||
| Helen | Female | 12–15 | ||
| Rob | Male | 12–15 | ||
| Peter | Male | 12–15 | ||
| John | Male | 12–15 | ||
| Healthcare professionals | ||||
| Pseudonyms | Role | Length of experience in cystic fibrosis care (years) | ||
| Sarah | Physiotherapist | >20 | ||
| Laura | Nurse specialist | 10–15 | ||
| Joan | Respiratory physiologist | 10–15 | ||
| Kate | Physiotherapist | 1–4 | ||
| Jade | Consultant | 10–15 | ||
| Linda | Dietician | 1–4 | ||
| Emma | Nurse specialist | >20 | ||
| Mary | Physiotherapist | 10–15 | ||
| Julie | Physiotherapist | 1–4 | ||
| Suzi | Physiotherapist | 5–9 | ||
FEV1 %, forced expiratory volume in 1 s percentage predicted.